Fenafluke 5% w/v Oral Suspension
Fenafluke 5% w/v Oral Suspension
Authorised
- Rafoxanide
- Fenbendazole
Product identification
Medicine name:
Fenafluke 5% w/v Oral Suspension
Active substance:
- Rafoxanide
- Fenbendazole
Target species:
-
Cattle
-
Sheep
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Rafoxanide50.00milligram(s)1.00millilitre(s)
-
Fenbendazole50.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
- Cattle
-
Meat and offal60day
-
- Sheep
-
Meat and offal60day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC13
- QP52AX
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- 1L (jerrican) HDPE white containers closed with a polypropylene screw-cap with an induction heat seal liner.
- 5L (jerrican) HDPE white containers closed with a polypropylene screw-cap with an induction heat seal liner.
- 2.5L (backpack) HDPE white containers closed with a polypropylene screw-cap with an induction heat seal liner.
- 2.5L (jerrican) HDPE white containers closed with a polypropylene screw-cap with an induction heat seal liner.
- 1L (flexipack) HDPE white containers closed with a polypropylene screw-cap with an induction heat seal liner.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Pharvet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Pharvet Limited
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10462/003/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 8/04/2022
How useful was this page?: